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Preeclampsia is the disease of decades. During the 20th century there were seven quantum leaps or 
discoveries recorded. First, the discovery of the infl atable armband permitting to measure blood pressure 
in 1896. Second, the discovery that eclamptic (convulsions), and later “pre”eclamptic (proteinuria) women 
presented hypertension in 1897 and confi rmed in 1903, the discovery of the hypertensive disorders 
of pregnancy. Third, the eight major textbooks published all along the 20th century by delineating 
risk factors of preeclampsia with the concept of “preeclampsia, disease of primigravidae”. Fourth, the 
discovery in the 1970’s that human trophoblast implantation was far deeper than in other mammalian 
species. Fifth, and a major step forward, description at the end of the 1980’s that the maternal syndrome 
in preeclampsia (glomeruloendotheliosis, HELLP syndrome, eclampsia) could be unifi ed in a global 
endothelial cell infl ammation. Sixth, the epidemiological descriptions in the 1970–1990’s that indeed 
preeclampsia was a disease of fi rst pregnancies at the level of a couple (“primipaternity concept”), 
leading to an explosion in immunological research in the last decade, beginning in 1998. Seventh and 
fi nally, in the search for the “factor X” explaining the vascular infl ammation in preeclamptic women 
(inositol phospho glycans P-type were described in 2000, while soluble Flt-1 and S-endoglins have been 
clearly predicted since 1997). The majority of the seeds or fi ndings have been grounded or realized 
in the 20th century. Indeed, for preeclampsia, the 20th century has been le “Siècle des Lumières” (the 
Enlightenment).1
So, where are we now? Have we won the war yet?In reality, we as humankind are living in the same 
one house named “The World” but with highly diverse in way of life, culture and destiny. We are 
different in almost every aspect of life, so are the differences in the prevalence, morbidity and mortality 
of preeclampsia.Although there is likely to accept the dictum that “Eclampsia is a disease of the past”, 
but at the same time stroke, pulmonary oedema or cardiovascular complications are becoming common 
complications leading to maternal death of severe preeclampsia.2-4
In the developed world, where health facilities including emergent caesarean delivery and well-
provided health assurance are available, the burden of morbidity and mortality due to preeclampsia are 
reasonably lighter compared to the other part of the world.
Let us together hand in hand as the family of the same world, collaborate against this mother’s killer 
number one. Implementation of human genome project into personalised medicine, dissemination of 
Colabs program, international collaborations, training program and workshops, sharing experiences, 
socialising guidelines and standard protocols, etc are among others kind of activitieswhich has to be 
enhanced in the years to come.We are still in the middle of the battlefi eld.
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